Zealand Pharma discloses amylin as the biological target under their 2014 agreement with Boehringer Ingelheim

https://www.globenewswire.com/news-release/2017/05/11/982276/0/en/Zealand-Pharma-discloses-amylin-as-the-biological-target-under-their-2014-agreement-with-Boehringer-Ingelheim.html

press release